Suraksha Diagnostic (544293) Stock Overview
Operates a chain of diagnostic centers in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 544293 from our risk checks.
544293 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Suraksha Diagnostic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹290.15 |
| 52 Week High | ₹449.00 |
| 52 Week Low | ₹233.15 |
| Beta | 0 |
| 1 Month Change | -9.78% |
| 3 Month Change | -2.75% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 544293 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -3.6% | -0.5% | -0.5% |
| 1Y | n/a | 17.1% | 2.5% |
Return vs Industry: Insufficient data to determine how 544293 performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how 544293 performed against the Indian Market.
Price Volatility
| 544293 volatility | |
|---|---|
| 544293 Average Weekly Movement | 3.5% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: 544293 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 544293's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,300 | Ritu Mittal | www.surakshanet.com |
Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test.
Suraksha Diagnostic Limited Fundamentals Summary
| 544293 fundamental statistics | |
|---|---|
| Market cap | ₹15.12b |
| Earnings (TTM) | ₹319.26m |
| Revenue (TTM) | ₹2.76b |
Is 544293 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 544293 income statement (TTM) | |
|---|---|
| Revenue | ₹2.76b |
| Cost of Revenue | ₹408.04m |
| Gross Profit | ₹2.35b |
| Other Expenses | ₹2.03b |
| Earnings | ₹319.26m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.13 |
| Gross Margin | 85.21% |
| Net Profit Margin | 11.57% |
| Debt/Equity Ratio | 1.2% |
How did 544293 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/27 07:13 |
| End of Day Share Price | 2025/11/27 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Suraksha Diagnostic Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hrishikesh Patole | Batlivala & Karani Securities India Pvt. Ltd. |
| Anshuman Gupta | Investec Bank plc (UK) |